Eli Lilly | Revenu Net



Net Income Changement Date
AbbVie USD 1.29B 1.31B 2025-03
Abbott USD 1.33B 7.9B 2025-03
ALKERMES USD 367.07M 274.69M 2024-12
Amgen USD 627M 2.2B 2024-12
AstraZeneca USD 2.92B 1.42B 2025-03
Baxter International USD -512000000 652M 2024-12
Biogen USD 266.7M 121.8M 2024-12
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Drreddys Laboratories INR 14.13B 1.58B 2024-12
Eli Lilly USD 4.41B 3.44B 2024-12
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
Glaxosmithkline GBP 414M 472M 2024-12
Indivior 48M 11M 2025-03
J&J USD 11B 7.57B 2025-03
Medtronic USD 1.29B 25M 2025-01
Merck USD 5.08B 1.34B 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
Novartis USD 2.82B 371M 2024-12
Novo Nordisk 27.3B 7.25B 2024-09
Perrigo USD -44500000 23.5M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Prestige Brands USD 61.03M 6.65M 2024-12
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
Sanofi EUR 499M 2.32B 2024-12
United Therapeutics USD 322.2M 20.9M 2025-03
Zoetis USD 581M 101M 2024-12



Eli Lilly Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.